Luveris (Serono) en es it fr

Luveris (Serono) Brand names, Luveris (Serono) Analogs

Luveris (Serono) Brand Names Mixture

  • No information avaliable

Luveris (Serono) Chemical_Formula

C1014H1609N287O294S27

Luveris (Serono) RX_link

No information avaliable

Luveris (Serono) fda sheet

Luveris (Serono) msds (material safety sheet)

Luveris (Serono) Synthesis Reference

No information avaliable

Luveris (Serono) Molecular Weight

23390.3

Luveris (Serono) Melting Point

55 oC (Forastieri, H., Ingham, K.C. J. Biol. Chem. 257:7976-7981 (1982))

Luveris (Serono) H2O Solubility

No information avaliable

Luveris (Serono) State

Liquid

Luveris (Serono) LogP

-0.063

Luveris (Serono) Dosage Forms

Solution (Subcutaneous Injection)

Luveris (Serono) Indication

For treatment of female infertility

Luveris (Serono) Pharmacology

Used to facilitate female conception, lutropin alfa performs the same actions as luteinizing hormone (LH), which is normally produced in the pituitary gland. Lutropin is usually given in combination with follitropin alfa. In females, a LH surge about halfway through the menstrual cycle triggers the onset of ovulation. LH also induces the ovulated follicle to become a corpus luteum, which then secretes progesterone.

Luveris (Serono) Absorption

No information avaliable

Luveris (Serono) side effects and Toxicity

No information avaliable

Luveris (Serono) Patient Information

No information avaliable

Luveris (Serono) Organisms Affected

Humans and other mammals